Orgenesis Inc ORGS
Trading Information
- Previous Close Price
- $0.55
- Day Range
- $0.35–0.35
- 52-Week Range
- $0.00–1.00
- Bid/Ask
- $1.12 / $1.25
- Shares Outstanding
- 9.80M
- Market Cap
- $3.43M
- Volume/Avg
- 250 / 487
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies. The company's therapies pipeline includes Immuno-Oncology, Viral Diseases, Metabolic & Autoimmune Diseases, Vascular & Musculoskeletal Diseases, and Kidney Disease.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 77
- Website
- https://www.orgenesis.com
Valuation
|
Metric
|
ORGS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ORGS
Financial Strength
|
Metric
|
ORGS
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.03 |
Interest Coverage | −12.09 |
Quick Ratio
ORGS
Profitability
|
Metric
|
ORGS
|
|---|---|
Return on Assets (Normalized) | −76.36% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ORGS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|d^x#^?B | LOCK|qQTTz | $129B | |||
| Moderna Inc
MRNA
| LOCK|pf#s<!< | LOCK|%! | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|hJR@$$ | LOCK|@#M?x | $79B | |||
| argenx SE ADR
ARGX
| LOCK|fFdVSPN | LOCK|h?t | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|wmV%vX | LOCK|^$ | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|st@KpH | LOCK|yCQ> | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|@jXgh&v% | LOCK|bg?kw | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|??>!lJx | LOCK|h^ | $24B | |||
| Incyte Corp
INCY
| LOCK|@krZ^& | LOCK|s#z | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|^!q!<b> | LOCK|^& | $14B |
United States